Investigation into the role of MicroRNAs in pathogenesis of Marek's disease
Lead Research Organisation:
The Pirbright Institute
Department Name: Div of Microbiology Compton
Abstract
Marek's disease is one of the most contagious and widespread diseases affecting poultry health and welfare. The causative virus, called Marek's disease virus (MDV) induces a very severe form of cancer of the white blood cells (lymphocytes). Once infected, the virus can persist for the lifetime of the host and is continuously shed from the feather of the infected birds into the environment where it survives for long periods. The mechanisms by which MDV causes cancer is not known. The present project is aimed to identify the mechanisms of causation of the disease by the virus. Recently, several small RNA molecules called microRNAs (miRNAs) have been shown to be involved in different cellular processes including several human cancers. Such small miRNA molecules have been found in the chickens and we have also recently identified several miRNAs in the virus. The present project is aimed to examine whether these small miRNA are involved in the causation of MD.
Technical Summary
Marek's disease (MD) is one of the most highly oncogenic herpesviruses known. The causative Marek's disease virus (MDV) is an alphaherpesvirus encoding more than 100 open reading frames. Molecular mechanisms of oncogenesis of MD are not fully understood, although the role of several MDV genes in oncogenesis have been identified. Recently, there has been great interest in the role of non-coding RNAs, particularly the 21-25 nucleotide microRNAs (miRNAs), in various biological processes. In chickens, 122 miRNAs have been identified, although their functional role is not yet clear. Very recently, novel miRNA sequences have also been identified in several herpesviruses. Using new bioinformatic tools, we have identified 9 novel miRNA sequences in the MDV genome, eight of which are clustered in the repeat regiion. This project is aimed to analyse the role of chicken miRNAS and the novel MDV miRNAS by examining their expression profiles and by identifying the potential targets. Finally, using mutagenesis of the bacterial artificial chromosome (BAC) clones of virulent MDV strains, we will examine whether the novel MDV miRNAs are involved in the pathogenesis of MD. The project would provide a fundamental understanding not only on the molecular mechanisms of MDV oncogenicity, but also on the novel methods of gene regulation associated with neoplasia in general.
Organisations
Publications
Mwangi W
(2010)
Regional and global changes in TCRaß T cell repertoires in the gut are dependent upon the complexity of the enteric microflora
in Developmental & Comparative Immunology
Tahiri-Alaoui A
(2009)
The 5' leader of the mRNA encoding the marek's disease virus serotype 1 pp14 protein contains an intronic internal ribosome entry site with allosteric properties.
in Journal of virology
Tahiri-Alaoui A
(2009)
Identification of an intercistronic internal ribosome entry site in a Marek's disease virus immediate-early gene.
in Journal of virology
Xu H
(2008)
Analysis of the expression profiles of Marek's disease virus-encoded microRNAs by real-time quantitative PCR.
in Journal of virological methods
Yao Y
(2008)
MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs.
in Journal of virology
Yao Y
(2018)
Inhibition of v-rel-Induced Oncogenesis through microRNA Targeting.
in Viruses
Zhao Y
(2009)
A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus.
in Journal of virology
Description | One of the significant key finding from this grant was the demonstration of the role of a single virus-encoded microRNA miR-M4 in producing lymphoma. Using CRISPR/Cas9-based deletion of MDV-miR-M4, we have recently shown that continued expression of miR-M4 however is not essential to maintain the transformed phenotype. |
Exploitation Route | The findings from the project in the different publications will advance science and can be taken for translational applications against viruses and cancers |
Sectors | Agriculture Food and Drink Healthcare Pharmaceuticals and Medical Biotechnology |
Description | Defining the cistrome and quantitative transcriptome of virus-transformed cells 12. BB/I014284/1 'Defining the cistrome and quantitative transcriptome of virus-transformed cells'- New grant funded by BBSRC April 2012- March 2015 (£548K). |
Amount | £548,000 (GBP) |
Funding ID | BB/I014284/1 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 03/2012 |
End | 03/2015 |
Description | Innovations in control of avian infectious diseases for sustainable growth and food security in low and middle income countries |
Amount | £355,000 (GBP) |
Organisation | The Royal Society |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 12/2016 |
End | 11/2021 |